Biontech Se
-
{
- All
- News
-
What To Know About COVID-19 Vaccine For US Children
The US Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. The vaccine from Pfizer Inc and BioNTech SE has been available in the United States to kids aged 12 to 15 since May.
-
BioNTech CEO Reveals "Biggest Challenge" After Covid Vaccine Gets US Nod
The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up manufacturing to meet huge demand.
-
BioNTech Founder Now Among World's Richest After UK Clears Vaccine
Ugur Sahin just reached another milestone.
-
What To Know About COVID-19 Vaccine For US Children
The US Food and Drug Administration is considering authorizing a COVID-19 vaccine for children aged 5 to 11. The vaccine from Pfizer Inc and BioNTech SE has been available in the United States to kids aged 12 to 15 since May.
-
BioNTech CEO Reveals "Biggest Challenge" After Covid Vaccine Gets US Nod
The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their COVID-19 vaccine is authorized for use in the United States will be to scale up manufacturing to meet huge demand.
-
BioNTech Founder Now Among World's Richest After UK Clears Vaccine
Ugur Sahin just reached another milestone.
